The drug showed promising results in an international study involving nearly 2,400 participants, and the U.S. Food and Drug ...
By Bhanvi Satija and Puyaan Singh May 22 (Reuters) - The European Medicines Agency recommended approval of Novo Nordisk's ...
Novo Nordisk (NVO) stock is in focus as the company wins EU backing for its oral weight loss therapy, the Wegovy pill. Read ...
Manufacturer Novo Nordisk has partnered with telehealth companies and other weight-loss groups to increase access to the pill, starting at $149 a month Novo Nordisk/FDA The Wegovy pill, which is ...
The recommendation paves the way for it to become the first tablet approved to treat obesity in the European Union.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results